Dr. Senderowicz was previously Senior Vice President and Chief Medical Officer at Constellation Pharmaceuticals, where he was responsible for the development of a portfolio of compounds leveraging epigenetics.

Before Constellation, Dr. Senderowicz was chief medical officer at Cerulean Pharma, where he helped secure fast-track designation for the company’s lead clinical program in two indications.

Previously, Dr. Senderowicz held roles of increasing responsibility at Ignyta, Inc, Sanofi Oncology, Tokai Pharmaceuticals and AstraZeneca plc.

He began his career as an investigator at the National Cancer Institute before joining the FDA’s CDER. Adrian conducted his Internal Medicine residency training at the Icahn School of Medicine at Mount Sinai and a Clinical Oncology Fellowship at the NCI. He holds an MD from the School of Medicine at the Universidad de Buenos Aires (Argentina). Dr. Senderowicz also sits on the board of Puma Biotechnology


Our board of directors is made up of seasoned industry investors and executives who provide their leadership and experience as we progress our promising pipeline into the clinic.